News
The Great Solar Eclipse of 2024: A Once-in-a-Lifetime Celestial Spectacle
The 2024 total solar eclipse: a rare event uniting millions, set to create unforgettable memories for generations.
Last Updated on December 21, 2024 by Daily News Staff
In just 75 days, North America will bear witness to a rare and awe-inspiring event—the total solar eclipse. This celestial phenomenon will cast parts of 15 U.S. states, alongside sections of Mexico and Canada, into an extraordinary darkness during the day. This upcoming eclipse brings to mind the monumental solar eclipse of January 24, 1925, which left an indelible mark on the U.S. Northeast, particularly in New York City.
Back in 1925, the eclipse divided the city, creating a unique dichotomy between those who experienced totality and those who witnessed only a partial eclipse. The boundary of the path of totality, initially predicted to be 83rd Street, was expected to split Manhattan into two distinct viewing experiences. However, the actual boundary was revealed to be 96th Street, and the eclipse arrived four seconds behind schedule, challenging the preconceived notions of the event.
As we eagerly anticipate the upcoming eclipse, it’s essential to reflect on the lessons learned from historical mispredictions. The precision of modern eclipse predictions has significantly improved, yet numerous variables still influence each event. Factors such as the moon’s terrain, observer’s elevation, Earth’s rotation speed, and the apparent size of the sun contribute to the uniqueness of each eclipse. Understanding these variables is crucial, especially for those living on the edge of totality, as seen in cities like San Antonio and Austin, Texas.
The upcoming eclipse provides an opportunity for cities like Rochester, New York, to relive a momentous event that last occurred in 1925. With preparations underway for the ROC the Eclipse festival at the Rochester Museum & Science Center, the community eagerly awaits the chance to witness a 3 minutes 40 seconds totality—a significantly longer duration than in 1925.
The anticipation for this celestial event serves as a unifying force, offering a positive shared experience for millions. As Dan Schneiderman, Eclipse Partnership Manager at the Rochester Museum & Science Center, aptly puts it, “We want people to have that positive shared experience they always remember, so random strangers can ask each other ‘where were you during that total solar eclipse?’”
The forthcoming total solar eclipse on April 8, 2024, is a once-in-a-lifetime opportunity for millions across the 15 fortunate U.S. states. It presents a chance to marvel at the wonders of the universe, uniting communities in an extraordinary shared experience. As we approach this historic event, let us embrace the opportunity to witness the splendor of the cosmos and create lasting memories that will be cherished for generations to come.
Author
Lifestyle
Mother’s Day Celebration: Honoring the Hardest Job in the World
“On Mother’s Day, let’s celebrate the sacrifices and unwavering love of mothers. Join us in honoring the hardest job in the world – motherhood.”
Last Updated on May 4, 2026 by Daily News Staff
Mother’s Day is a special day that celebrates the hard work and dedication of mothers around the world. Being a mother is one of the most difficult jobs there is, yet it is also one of the most rewarding. Mothers work tirelessly to care for their children, often sacrificing their own needs and wants in order to provide for their families.
On Mother’s Day, it is important to take the time to show appreciation for all that mothers do. Whether it’s a simple card, a bouquet of flowers, or a heartfelt message, any gesture of gratitude can go a long way in letting mothers know that their efforts are valued and appreciated.
However, it’s important to remember that Mother’s Day is not just about gifts and presents. It’s a day to acknowledge the sacrifices that mothers make on a daily basis, and to recognize the love and care that they provide to their families.
Mothers work hard to instill values, provide guidance and support, and create a safe and nurturing home environment for their children. They are often the backbone of the family, and their contributions cannot be overstated.
So, on this Mother’s Day, let us take the time to celebrate the mothers in our lives. Let us thank them for their hard work, their sacrifices, and their unwavering love and support. Let us show them that they are valued and appreciated, not just on this special day, but every day of the year.
https://en.wikipedia.org/wiki/Mother%27s_Day
https://stmdailynews.com/category/lifestyle/
Author
Lifestyle
Reclassification of marijuana opens doors for much‑needed medical research into the benefits and risks of the drug
The DOJ’s move to reclassify medical marijuana as Schedule III could unlock long-blocked cannabis research—while raising new questions about safety, regulation, and risk.
Carey S. Cadieux, Binghamton University, State University of New York
When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for decades by its more restrictive Schedule I classification.
The Justice Department also called for an expedited federal rescheduling process, with proceedings expected to begin in late June 2026, but for now cannabis at the federal level remains a Schedule I drug.
I’m an associate professor of nursing and I edited a textbook for nurses about providing care with cannabis. Cannabis is the umbrella term for the plant genus that includes both marijuana and hemp – two varieties of the same plant distinguished primarily by their content of THC, one of the active components of cannabis.
Moving cannabis to a Schedule III drug ushers in the end of the cannabis prohibition era and the beginning of the regulation era, potentially creating promising opportunities around research and new therapeutics.
How are drugs regulated by ‘schedule’?
The Controlled Substances Act of 1970 categorizes all substances regulated under existing federal law into one of five schedules. The act regulates the manufacturing, importation, possession, use and distribution of substances on each schedule.
Several factors determine schedule placement, including the drug’s medical use, scientific evidence of its benefits and pharmacological effects, patterns and history of abuse, public health risk level, degree of physical or psychological addiction potential, and whether the drug can be used to make another controlled substance.
The Drug Enforcement Administration’s rescheduling of marijuana will move it from its current classification as a Schedule I drug, defined as having a high risk for abuse and no accepted medical use, to a Schedule III drug under the Controlled Substances Act. While still tightly regulated, Schedule III drugs are considered to have moderate to low risk for physical and psychological dependence and to have some medical benefits.
Other Schedule I drugs include heroin, psilocybin, LSD, peyote and MDMA, or ecstasy. These drugs cannot be dispensed or prescribed, with some exceptions. Current Schedule III drugs include ketamine, anabolic steroids, testosterone, products with less than 90 milligrams of codeine per dosage unit and some cannabinoids.
The move to reclassify medical marijuana products as Schedule III drugs applies only to those products certified by state-level medical cannabis programs. All other cannabis products remain a federal Schedule I drug, including those available from states’ recreational cannabis programs.
Impacts of cannabis reclassification
This legal order acknowledges that medical marijuana has some medical value and asserts that it has a lower potential for abuse than under the previous Schedule I classification.
The reclassification also ensures that state-registered medical cannabis patients continue to be permitted to purchase medical cannabis products without changes to their current certification or recommendation.
One of the challenges with this new law is that states have not standardized medical cannabis regulations, and each state will have its own quality and testing standards. In Maine, for instance, medical cannabis is not tested for molds, fungus, heavy metals or pesticides, while recreational cannabis is.
This means that the Schedule III medical cannabis in Maine could be contaminated, while the state’s testing of recreational cannabis makes it much safer to consume.
What are the implications for marijuana research?
For decades, researchers have struggled to conduct high-quality research studies due to their lack of access to the cannabis products that patients actually use and restrictions on their processes.
With the reclassification, researchers who are registered with the DEA to research cannabis will be able to obtain cannabis flower and plant material, as well as manufactured cannabis products, such as tinctures and edibles, directly from state-licensed businesses that are DEA-registered.
This means researchers will no longer need to rely on the federal DEA registry for access to cannabis products for research, which were often inferior in quality and variety in comparison to the everyday products medical cannabis patients typically have access to. Instead, they will be able to study cannabis products that patients use in daily life, such as vapes and various edible products.
This shift in access will now allow researchers to undertake the gold standard of research approaches: the randomized controlled trial.
Randomized controlled trials will help researchers like my colleagues determine how effective cannabis is in treating people with complex medical needs. This includes patients who experience nausea and pain while undergoing cancer treatments, multiple sclerosis patients with severe muscle spasm and stiffness, and chronic pain patients who strive to find relief without using opioids.
Might rescheduling send mixed signals?
Rescheduling may lead people to believe that cannabis is safe for all people to consume.
However, a growing body of research points to possible adverse effects from cannabis use, particularly in vulnerable groups, such as people who are pregnant, adolescents, people with preexisting mental health conditions such as schizophrenia or psychosis, and those with cardiac issues.
Cannabis can also lead to adverse drug interactions. Therefore, medical patients should use it with discretion and under the guidance of a healthcare professional.
For most medical cannabis patients, THC doses should start low and gradually be increased.
Rescheduling will be a big step toward helping researchers build a greatly needed solid body of evidence around both the benefits and potential harms of cannabis. But rescheduling should not be interpreted as a signal that cannabis is harmless.
Carey S. Cadieux, Associate Professor of Nursing, Binghamton University, State University of New York
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Our Lifestyle section on STM Daily News is a hub of inspiration and practical information, offering a range of articles that touch on various aspects of daily life. From tips on family finances to guides for maintaining health and wellness, we strive to empower our readers with knowledge and resources to enhance their lifestyles. Whether you’re seeking outdoor activity ideas, fashion trends, or travel recommendations, our lifestyle section has got you covered. Visit us today at https://stmdailynews.com/category/lifestyle/ and embark on a journey of discovery and self-improvement.
Automotive
Nissan’s New Strategy: Innovation Meets Consolidation in a Changing Auto Market
Nissan’s New Strategy: Nissan is reshaping its lineup with fewer models, more hybrid technology, and smarter vehicles. Here’s what’s staying, what’s changing, and what it means for drivers.
Nissan’s New Strategy
As the global auto industry pivots toward electrification and smarter technology, Nissan is taking a more measured approach—introducing new innovations while trimming its lineup to focus on core models that drive sales and long-term value.
🚗 A Leaner, More Focused Nissan
In recent years, Nissan has begun reshaping its global strategy, reducing the total number of models while strengthening key vehicles across major segments. The goal is clear: prioritize profitability, streamline production, and invest in technology where it matters most.
Rather than flooding the market with new nameplates, Nissan is concentrating on a smaller, more competitive lineup—particularly in high-demand categories like SUVs and crossovers.
🔋 Innovation Where It Counts
Hybrid Technology Takes Center Stage
One of Nissan’s most important developments is its e-POWER hybrid system, which is set to debut more broadly in the U.S., particularly in the next-generation Nissan Rogue.
Unlike traditional hybrids, e-POWER uses a gasoline engine solely to generate electricity, while the wheels are driven by an electric motor. The result is a driving experience that feels closer to an EV—without requiring a charging station.
This technology reflects a growing industry reality: while electric vehicles are expanding, hybrids are emerging as a practical bridge for many consumers.
EV Evolution, Not Explosion
Nissan isn’t abandoning electric vehicles—it’s refining its approach.
The iconic Nissan LEAF is expected to return in a redesigned, crossover-style format, aimed at improving range, comfort, and mainstream appeal. However, Nissan is avoiding an aggressive all-electric push in favor of a balanced portfolio that includes gas, hybrid, and EV options.
Smarter Vehicles Through AI
Another key pillar of Nissan’s future is AI-assisted driving technology. The company plans to integrate advanced driver assistance and semi-autonomous features into a majority of its vehicles over the next several years.
These systems are designed to enhance:
- Safety
- Driver awareness
- In-car connectivity
While less visible than a new engine or redesign, this shift could become one of Nissan’s most impactful long-term innovations.
🚙 The Core Lineup: What’s Staying
Nissan’s future lineup is built around a group of proven, high-demand models that continue to evolve with new technology and features.
SUVs and Crossovers (The Backbone)
- Nissan Kicks – Entry-level, affordable, and recently redesigned
- Nissan Rogue – The brand’s best-seller and innovation leader
- Nissan Pathfinder – Family-focused with growing tech upgrades
- Nissan Armada – Large SUV with premium and performance appeal
These vehicles form a complete SUV ladder, covering nearly every price point and lifestyle.
Sedans (Reduced but Relevant)
- Nissan Sentra – Recently updated and positioned as the primary sedan
- Nissan Altima – Still available, though its long-term future is less certain
As consumer demand shifts toward SUVs, Nissan is scaling back—but not eliminating—its sedan offerings.
Trucks and Performance Models
- Nissan Frontier – A key player in the midsize truck segment
- Nissan Titan – Still present, but facing stiff competition
- Nissan Z – A modern revival of Nissan’s performance heritage
- Nissan GT-R – Nearing the end of its lifecycle, with a successor anticipated
These models help maintain Nissan’s identity beyond everyday transportation.
⚠️ Models Being Phased Out or Reevaluated
Not every vehicle is making the cut.
- The Nissan Versa is being discontinued after 2025
- The Nissan Ariya is seeing strategy adjustments depending on market demand
- Some low-volume global models are being eliminated as part of a broader consolidation effort
This reflects a broader industry shift: automakers are prioritizing efficiency and profitability over sheer volume.
🔍 The Role of the Nissan Kicks
One standout in this transition is the Nissan Kicks, which represents Nissan’s practical, value-driven approach.
Recently redesigned, the Kicks offers:
- Modern infotainment and safety features
- Improved comfort and available all-wheel drive
- Strong fuel efficiency at an affordable price point
While it doesn’t showcase cutting-edge hybrid or EV technology, it plays a crucial role as an entry-level gateway into the Nissan brand.
🧭 Industry Context: Why This Shift Matters
Nissan’s strategy mirrors broader trends shaping the automotive industry:
- EV adoption is growing—but unevenly
- Hybrids are gaining traction as a transitional solution
- SUV demand continues to dominate global markets
- Cost control and profitability are now top priorities
By focusing on fewer, stronger models, Nissan aims to remain competitive in a rapidly evolving landscape.
🧾 Bottom Line
Nissan is not simply cutting models—it’s redefining its identity.
- ✔️ Investing in hybrid technology, AI, and core SUVs
- ✔️ Maintaining key sedans, trucks, and performance vehicles
- ❌ Eliminating underperforming and low-demand models
The result is a lineup that is leaner, more technologically advanced, and better aligned with today’s market demands.
Sources
- Nissan to trim global car lineup, boost use of AI driving tech – Reuters
- 2027 Nissan Rogue Revealed with New Design and e-POWER Hybrid – Car and Driver
- 2027 Nissan Rogue Hybrid Preview – Autoweek
- Nissan CEO Confirms Xterra Return – Road & Track
- Nissan Kicks Official Page – Nissan USA
Related External Links
- Explore the Nissan Rogue – Official Site
- Nissan LEAF Electric Vehicle Overview
- Latest Nissan News and Reviews – Car and Driver
- Nissan Vehicle Reviews and Comparisons – MotorTrend
- Nissan News Coverage – Autoweek
Welcome to the Consumer Corner section of STM Daily News, your ultimate destination for savvy shopping and informed decision-making! Dive into a treasure trove of insights and reviews covering everything from the hottest toys that spark joy in your little ones to the latest electronic gadgets that simplify your life. Explore our comprehensive guides on stylish home furnishings, discover smart tips for buying a home or enhancing your living space with creative improvement ideas, and get the lowdown on the best cars through our detailed auto reviews. Whether you’re making a major purchase or simply seeking inspiration, the Consumer Corner is here to empower you every step of the way—unlock the keys to becoming a smarter consumer today!
